-

Hologic to Webcast Presentation at the 41st Annual J.P. Morgan Healthcare Conference

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 1:30 p.m. Pacific Time.

The presentation and Q&A session will be webcast live and may be accessed through a link on the Investors section of Hologic’s website at http://investors.hologic.com. The webcast will be available for 30 days following the event.

About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com

SOURCE: Hologic, Inc.

Contacts

Paula Izidoro
Manager, Investor Relations and Social Media
(858) 410-8904
paula.izidoro@hologic.com

Hologic, Inc.

NASDAQ:HOLX

Release Summary
Hologic to Webcast Presentation at the 41st Annual J.P. Morgan Healthcare Conference
Release Versions
$Cashtags

Contacts

Paula Izidoro
Manager, Investor Relations and Social Media
(858) 410-8904
paula.izidoro@hologic.com

Social Media Profiles
More News From Hologic, Inc.

Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio...

Hologic Announces Financial Results for First Quarter of Fiscal 2026

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Announces Financial Results for First Quarter of Fiscal 2026...

Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026...
Back to Newsroom